• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7278
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/26/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The patient/family was the initial reporter, so personal information was not entered.No information was captured as the customer's weight was not provided.
 
Event or Problem Description
The customer reported that he performed blood glucose testing with the contour next ez meter and obtained readings of 138 mg/dl at 10:03 a.M.And 142 mg/dl at 10:06 a.M.The meter automatically marked them as control tests, and so the readings will be displayed as control results when accessing the meter's memory.There was no allegation of an adverse event.The customer was advised to return the device for evaluation.Replacement meter kit and test strips were sent to the customer.
 
Additional Manufacturer Narrative
The customer did not return the device for evaluation.The contour next test strips associated with the event expired in oct-2022 respectively, therefore, an in-house testing could not be performed.The device history record was reviewed for the suspected contour next ez meter and no manufacturing anomalies were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Common Device Name
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
PHC CORPORATION (REGISTRATION NUMBER: 1000134386)
2131-1 minamigata
toon ehime, 791-0 395
JA   791-0395
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key13770850
Report Number1810909-2022-00043
Device Sequence Number17099400
Product Code NBW
UDI-Device Identifier10301937278706
UDI-Public10301937278706
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K111268
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 02/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date10/31/2022
Device Model Number7278
Device Catalogue Number7278
Device Lot Number0KPEC41A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/26/2022
Supplement Date Received by Manufacturer12/07/2022
Initial Report FDA Received Date03/15/2022
Supplement Report FDA Received Date12/12/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/01/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient Age75 YR
Patient SexMale
-
-